Laboratorios Inibsa will Produce Injectable for the French Market

CDM Lavoisier has chosen Laboratorios Inibsa as the best option for the pharmaceutical injectable manufacturing.

After several months of negotiations both Pharmaceutical Companies have signed a long-term contract for injectable ampoules for the French market.

The agreement includes the improvement of the CDM Lavoisier products quality with a longer shelf-life and updates the ampoule format from preprinted ones to labelled ampoules.

Yves Lambert, technical manager of CDM Lavoisier Laboratories, said: "After discussion and benchmarking we have chosen to establish a long term partnership with Inibsa due to the quality of the documentation provided, the quality of the equipment and the professionalism of the Inibsa team."